Tachycardia clinical trials at UC Irvine
1 in progress, 0 open to eligible people
Showing trials for
IgPro20 in Post-COVID-19 POTS
Sorry, not currently recruiting here
This is a prospective, phase 3, multicenter, double-blind, randomized placebo-controlled study to investigate the efficacy, safety, and pharmacokinetics (PK) of repeat doses of IgPro20 in participants with post SARS-CoV-2 infection 2019 postural orthostatic tachycardia syndrome (post-Coronavirus Disease 2019 [COVID-19] POTS [post-COVID-POTS]).
Orange, California and other locations
Last updated: